PUBLIKACE ČESKÝCH PEDIATRICKÝCH NEFROLOGŮ ZA POSLEDNÍ 4 ROKY V ČASOPISECH (HOME PUBMED)

• Urinary Neutrophil Gelatinase-Associated Lipocalin Does Not Distinguish Acute Rejection from Other Causes of Acute Kidney Injury in Pediatric Renal Transplant Recipients. Seeman T, Vondrak K, Fortova M, Sopko B, Průša R, Pohl M, John U. Clin Lab 2017 Jan 1; 63 (1): 111–114.
• Racial variation in cardiovascular disease risk factors among European children on renal replacement therapy-results from the European Society of Paediatric Nephrology//European RenalAssociation-European Dialysis and Transplant Association Registry. Tjaden LA, Seeman T, Noordzij M. Nephrol Dial Transplant 2017 Feb 1.
• Kidney Versus Combined Kidney and Liver Transplantation in Young People With Autosomal Recessive Polycystic Kidney Disease: Data From the European Society for Pediatric Nephrology/European Renal Association-European Dialysis and Transplant (ESPN/ERA-EDTA) Registry. Mekahli D, Seeman T, Groothoff JW. ESPN/ERA-EDTA Registry. Am J Kidney Dis 2016 Nov; 68 (5): 782–788.
• 2016 European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents. Lurbe E, Seeman T, Zanchetti A. J Hypertens 2016 Oct; 34 (10): 1887–920.
• Nocturnal blood pressure non-dipping is not associated with increased left ventricular mass index in hypertensive children without end-stage renal failure. Seeman T, Hradský O, Gilík J. Eur J Pediatr 2016 Aug; 175 (8): 1091–7. doi: 10.1007/s00431-016-2749-z. Epub 2016 Jun 25.
• Febrile urinary tract infection after pediatric kidney transplantation: a multicenter, prospective observational study. Weigel F, Seeman T, John U. Pediatr Nephrol 2016 Jun; 31 (6): 1021–8.
• Molecular genetic analysis of PKHD1 by next-generation sequencing in Czech families with autosomal recessive polycystic kidney disease. Obeidova L, Seeman T, Stekrova J. BMC Med Genet 2015 Dec 22; 16: 116.
• Can auscultatory blood pressure normative values be used for evaluation of oscillometric blood pressure in children? Šuláková T, Šuláková A, Obermannová B, Feber J. J Clin Hypertens (Greenwich) 2017 Apr; 19 (4): 381–387. doi: 10.1111/jch.12943. Epub 2016 Nov 7.
• The importance of pulse wave velocity measurement in paediatric population with an increased risk of cardiovascular diseases-Type 1 diabetes and chronic kidney disease. Šuláková T, Feber J,  Šumník Z. Cor et Vasa 2016; e1–e8.
• HbA1c but not diabetes duration predicts increased arterial stiffness in adolescents with poorly controlled type 1 diabetes. Echocardiographic evaluation of cardiac structure and function in children with hypertension. Pavlíček J, Šuláková T. Cor et Vasa 2016; e1–e8.
• Recurrence of nephrotic proteinuria in children with focal segmental glomerulosclerosis: early treatment with plasmapheresis and immunoadsorption should be associated with better prognosis. Fencl F, Vondrák K, Seeman T. Minerva Pediatr 2016 Oct; 68 (5): 348–54.
• Proteinuria 1 year after renal transplantation is associated with impaired graft survival in children. Rosik T, Chadimova M, Dušek J, Hacek J, Simankova N, Vondrak K, Zieg J, Seeman T. Pediatr Nephrol 2015 Oct; 30 (10): 1853–60.
• Genetic Drivers of Kidney Defects in the DiGeorge Syndrome. Lopez-Rivera E, Flogelova H, Sanna-Cherchi S. N Engl J Med 2017 Feb 23; 376 (8): 742–754. doi: 10.1056/NEJMoa1609009. Epub 2017 Jan 25.
• Isolated low initial differential renal function in patients with primary non-refluxing megaureter should not be considered an indication for early surgery: A multicentric study. Drlík M, Flogelová H, Drlik M, Kočvara R. J Pediatr Urol 2016 Aug; 12 (4): 231.
• Can renal ultrasonography and DMSA scintigraphy be used for the prediction of irreversible histological lesions of the upper pole in duplex system with ureteroceles or ectopic ureters? Smakal O, Flogelova H, Student V. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2016 Sep; 160 (3): 429–34.
• Renal parenchymal thickness in children with solitary functioning kidney. Flogelová H, Langer J, Šmakal O, Michálková K, Bakaj-Zbrožková L, Zapletalová J. Pediatr Nephrol 2014 Feb; 29 (2): 241–8.
• Rare ocular manifestation with suspect Alport syndrome. Krejčířová I, Varadyová B, Doležel Z, Autrata R, Matúšová J, Gregorová E. Cesk Slov Oftalmol 2014 Jun; 70 (3): 114–8.
• Transient hyperphosphatemia in a child with nephrolithiasis and severe prematurity. Kutilek S, Formanova D, Senkerik M, Langer J, Markova D, Skalova S. Nefrologia 2017 Mar 18.
• Transient hyperphosphatemia: a benign labolatory disorder in a boy with Gitelman syndrome. Skalova S, Kutilek S. J Bras Nefrol 2016 Jul-Sep; 38 (3): 363–365. doi: 10.5935/0101-2800.20160055. English, Portuguese.
• Serum homocysteine levels in children and adolescents with impaired bone health. Rehačkova P, Skalova S, Kutilek S. Rev Bras Reumatol 2013 Nov-Dec; 53 (6): 464–8. doi: 10.1016/j.rbr.2013.06.001.
• Intravenous pamidronate in the treatment of severe idiopathic infantile hypercalcemia. Skalova S, Cerna L, Bayer M, Kutilek S, Konrad M, Schlingmann KP. Iran J Kidney Dis 2013 Mar; 7 (2): 160–4.
• Gitelman syndrome as a cause of psychomotor retardation in a toddler. Skalova S, Neuman D, Lnenicka P, Stekrova J. Arab J Nephrol Transplant 2013 Jan; 6 (1): 37–9.
• Hyponatremia in children: from pathophysiology to therapy. Zieg J. Cas Lek Cesk 2016; 155 (3): 35-40.
• Current views on the diagnosis and management of hypokalaemia in children. Zieg J, Gonsorcikova L, Landau D. Acta Paediatr 2016 Jul; 105 (7): 762–72. Review.
• Psychiatric disorders are associated with increased risk for developing hyponatraemia in children. Zieg J, Glombova M. J Pediatr Endocrinol Metab 2015 Sep; 28 (9-10): 1195–6.
• Oral penicillin-associated acute kidney injury in an infant with acute pyelonephritis. Zieg J, Hacek J. Pediatr Int 2015 Apr; 57 (2): e62–4.
• Nephrotic syndrome and acute kidney injury in a patient treated with lithium carbonate. Zieg J, Šimánkova N, Hribal Z. Australas Psychiatry 2014 Dec; 22 (6): 591–2.
• Electrolyte disorders. Bockenhauer D, Zieg J. Clin Perinatol 2014 Sep; 41 (3): 575–90.
• Evaluation and management of hyponatraemia in children. Zieg J. Acta Paediatr 2014 Oct; 103 (10): 1027–34.
• Surprisingly favorable outcome in a patient with Goodpasture's disease. Zieg J, Hacek J. Hemodial Int 2013 Jan; 17 (1).
• HbA1c but not diabetes duration predicts increased arterial stiffness in adolescents with poorly controlled type 1 diabetes. Obermannova B, Petruzelkova L, Suláková T, Sumnik Z. Pediatr Diabetes 2017 Jun; 18 (4): 304–310.
• Should mean arterial pressure be included in the definition of ambulatory hypertension in children? Suláková T, Feber J. Pediatr Nephrol 2013 Jul; 28 (7): 1105–12. Pediatr Diabetes 2017 Jun; 18 (4): 304–310.
• Familial hematuria: A review. Plevová P, Gut J, Janda J.
• Medicina (Kaunas) 2017; 53 (1): 1–10.
• Circuit Lifetime With Citrate Versus Heparin in Pediatric Continuous Venovenous Hemodialysis. Zaoral T, Hladík M, Zapletalová J, Trávníček B, Gelnarová E. Pediatr Crit Care Med 2016 Sep; 17 (9).
• Transient hyperphosphatemia in a child with nephrolithiasis and severe prematurity. Kutilek Š, Šenkeřík M, Langer J, Skalova S. Nefrologia 2017 Mar 18.
• Enterohemorrhagic Escherichia coli as causes of hemolytic uremic syndrome in the Czech Republic. Marejková M, Bláhová K, Janda J, Fruth A, Petráš P. PLoS One 2013 Sep 6; 8 (9).
• Single-Nucleotide Polymorphism of CYP3A5 Impacts the Exposure to Tacrolimus in Pediatric Renal Transplant Recipients: A Pharmacogenetic Substudy of the TWIST Trial. Billing H, Vondrak K, Tönshoff B. Ther Drug Monit 2017 Feb; 39 (1): 21–28.
• Peritoneal Dialysis Access Revision in Children: Causes, Interventions, and Outcomes. Borzych-Duzalka D, Vondrak K, Warady BA. International Pediatric Peritoneal Dialysis Network (IPPN) Registry. Clin J Am Soc Nephrol 2017 Jan 6; 12 (1): 105–112.
• Safety and usage of darbepoetin alfa in children with chronic kidney disease: prospective registry study. Schaefer F, Hoppe B, Vondrak K. Pediatr Nephrol 2016 Mar; 31 (3): 443–53.
• Hemodialysis in children with ventriculoperitoneal shunts: prevalence, management and outcomes. Wright E, Vondrak K, Shroff R. European Paediatric Dialysis Working Group. Pediatr Nephrol 2016 Jan; 31 (1): 137-43.
• Anemia in children following renal transplantation-results from the ESPN/ERA-EDTA Registry. Krischock LA, Vondrak K, Seeman T, Schaefer F. ESPN/ERA-EDTA Registry. Pediatr Nephrol 2016 Feb; 31 (2): 325–33.
• IgA Nephropathy. Facts, uncertainties, and potential causal therapy approaches. Matoušovic K, Vondrák K, Dušek J, Raška M. Cas Lek Cesk 2015; 154 (4): 168–73.
• Pleuro-peritoneal or pericardio-peritoneal leak in children on chronic peritoneal dialysis – A survey from the European Paediatric Dialysis Working Group. Dufek S,
• Vondrak K, Shroff R. European Paediatric Dialysis Working Group. Pediatr Nephrol 2015 Nov; 30 (11): 2021–7.
• Considerable variations in growth hormone policy and prescription in paediatric end-stage renal disease across European countries-a report from the
• ESPN/ERA-EDTA registry. Van Huis M, Vondrak K, Groothoff JW. Nephrol Dial Transplant 2016 Apr; 31 (4): 609–19.
• Corticosteroid-free Kidney Transplantation Improves Growth: 2-Year Follow-up of the TWIST Randomized Controlled Trial. Webb NJ, Vondrak K, Tönshoff B. Transplantation 2015 Jun; 99 (6): 1178–85.
• Indications, technique, and outcome of therapeutic apheresis in European pediatric nephrology units. Paglialonga F, Vondrak K, Edefonti A. Pediatr Nephrol 2015 Jan; 30 (1): 103–11.
• Adherence to transition guidelines in European paediatric nephrology units. Forbes TA, Vondrak K, Stefanidis C. European Paediatric Dialysis Working Group. Pediatr Nephrol 2014 Sep; 29 (9): 1617–24.
• Adult height in patients with advanced CKD requiring renal replacement therapy during childhood. Harambat J, Bonthuis M, Schaefer F; ESPN/ERA-EDTA Registry. Clin J Am Soc Nephrol 2014 Jan; 9 (1): 92–9.
• Nationwide biopsy survey of renal diseases in the Czech Republic during the years 1994–2011. Maixnerova D, Kolsky A, Tesar V. J Nephrol 2015 Feb; 28 (1): 39–49.
• Long-term growth hormone treatment in short children with CKD does not accelerate decline of renal function: results from the KIGS registry and HYPERLINK "https://www.ncbi.nlm.nih.gov/pub-med/26198275"ESCAPE trial. German KIGS Board; ESCAPE Trial Group. Pediatr Nephrol 2015 Dec; 30 (12): 2145–51.
• Normal 25-hydroxyvitamin D Levels Are Associated with Less Proteinuria and Attenuate Renal Failure Progression in Children with CKD.; ESCAPE Trial Group (Dusek J). J Am Soc Nephrol 2016 Jan; 27 (1): 314–22. doi: 10.1681/ASN.2014090947.
• ADCK4-Associated Glomerulopathy Causes Adolescence-Onset FSGS. PodoNet Consortium. J Am Soc Nephrol 2016 Jan; 27 (1): 63–8.
• Markers of bone metabolism are affected by renal function and growth hormone therapy in children with chronic kidney disease: 4C Study Consortium (Dusek J). PLoS One 2015 Feb 6; 10 (2): e0113482. doi: 10.1371/journal.pone.0113482. eCollection 2015.
• Spectrum of steroid-resistant and congenital nephrotic syndrome in children: the PodoNet registry cohort. Trautmann A, Dusek J, Schaefer F. PodoNet Consortium. Clin J Am Soc Nephrol 2015 Apr 7; 10 (4): 592–600.
• Genetic screening in adolescents with steroid-resistant nephrotic syndrome. Lipska BS, Dusek J, Schaefer F. PodoNet Consortium. Kidney Int 2013 Jul; 84 (1): 206–13.
• Impact of graft loss among kidney diseases with a high risk of post-transplant recurrence in the paediatric population. Van Stralen KJ, Dusek J,. Jager KJ. ESPN/ERA-EDTA Registry. Nephrol Dial Transplant 2013.
• Reduced microvascular density in omental biopsies of children with chronic kidney disease. Burkhardt D, Malina M, Querfeld U. PLoS One  2016;11. doi: 10.1371/journal.pone.0166050.
• Late recovery of renal function by rituximab in a patient with Wegener’s granulomatosis. Malina M, Schmitt CP. Pediatr Nephrol 2013; 28: 511–514.
• Peripheral gangrene in children with atypical hemolytic uremic syndrome. Malina M, Schaefer F. Pediatrics 2013; 131: e331–5.
• Malina M,. Jankauskienė A, Hvizdošová-Kleščová A, Uhlík J, Malina M, Vajner L. Remodeling of fetoplacental arteries in rats due to chronic hypoxia. Exp Toxicol Pathol 2013; 65: 97–103.

Sestavil prof. MUDr. J. Janda, CSc